Although we have achieved significant results, there are still many issues that need to be explored in in-depth studies, such as the specificity in SBE-induced repression of SHH to enhance chemotherapeutic treatment of lung carcinoma drug resistance. This evidence concerns the gene SHH and lung carcinoma.